{"transactions":[{"id":799789,"issuer":{"id":4576,"kind":"organization","name":"Inhibrx Biosciences, Inc.","symbol":"INBX"},"owners":[{"id":51125,"kind":"person","name":"Matly David","position":1,"cik":"0002062665","reported_name":"Matly David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President"}}],"security":"Stock Option (right to buy)","published_at":"2026-04-27T20:48:53.000Z","date":"2026-04-24","kind":"grant","planned":false,"acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Twenty-five percent (25%) of the total shares subject to the stock option become exercisable on April 24, 2027, with the balance to vest and become exercisable in equal successive monthly installments for thirty-six (36) months thereafter, subject to the Reporting Person's continuous service to the Issuer through each vesting date."}],"balance_after":50000,"derivative":{"exercise_price":129.06,"expiration_date":"2036-04-24","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0002062665-26-000002","document":"wk-form4_1777322930.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2007919/000206266526000002/wk-form4_1777322930.xml","form_type":"4"}},{"id":1182205,"issuer":{"id":4576,"kind":"organization","name":"Inhibrx Biosciences, Inc.","symbol":"INBX"},"owners":[{"id":51125,"kind":"person","name":"Matly David","position":1,"cik":"0002062665","reported_name":"Matly David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President"}}],"security":"Stock Option (right to buy)","published_at":"2025-04-02T20:34:34.000Z","date":"2025-04-01","kind":"grant","planned":false,"acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Twenty-five percent (25%) of the total shares subject to this stock option will become exercisable on April 1, 2026, with the balance to vest and become exercisable in equal successive monthly installments for thirty-six (36) months thereafter, subject to the Reporting Person's continuous service to the Issuer through each vesting date."}],"balance_after":50000,"derivative":{"exercise_price":14.05,"expiration_date":"2035-04-01","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0002007919-25-000035","document":"wk-form4_1743626065.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2007919/000200791925000035/wk-form4_1743626065.xml","form_type":"4"}}]}